Blood Plasma Reveals Cancer

Quest Diagnostics Inc. has launched the first of its Leumeta cancer testing assays, designed as an alternative to bone marrow biopsies (which everyone would prefer to avoid). The assays identify and analyze genetic components of leukemia and lymphoma tumors using blood plasma instead of bone marrow, and can measure the amount of cancer in a patient, detect certain blood cancer markers, and assist the physician in monitoring the efficacy of the treatment being administered. (www.sensorsmag.com/0706/RDPlasma)

Suggested Articles

Semiconductor Industry Association makes pitch for tax incentives and grants to chipmakers to compete with other countries as backed by lawmakers

The Semiconductor Industry Association sees significant uncertainty for chip sales in coming months, although May numbers were up by 6% globally.

Micron saw record SSD sales, as Broadcom warned of a reset in its wireless business